Proteomics

Dataset Information

0

Inhibition of DOT1L increases osteoclast fusion and resorption and aggravates bone loss


ABSTRACT: Osteoclasts are absorptive cells and play a critical role in homeostatic bone remodeling and pathological bone resorption. Emerging evidence suggests an important role for epigenetic regulation of osteoclastogenesis. In this study, we investigated the role of DOT1L, which regulates gene expression epigenetically by histone H3K79 methylation during osteoclast formation. DOT1L and H3K79me2 levels were upregulated during osteoclast differentiation. Small molecule inhibitor- (EPZ5676 or EPZ004777) or short hairpin RNA-mediated reduction in DOT1L expression promoted osteoclast differentiation and resorption. DOT1L inhibition also increased osteoclast area and accelerated bone mass reduction in a mouse ovariectomy (OVX) model of osteoporosis. DOT1L inhibitors did not alter osteoblast differentiation in vitro and in vivo. Proteomics data, together with bioinformatics analysis, revealed that DOT1L inhibition altered reactive oxygen species (ROS) generation, autophagy activation, and cell fusion-related protein expression. ROS generation increased, and autophagy activation and cell migration ability enhancement were verified subsequently by flow cytometry and transwell migration assays. DOT1L inhibition increased NFATc1 nuclear translocation and NF-κB activation and strengthend osteoclast fusion and expression of resorption-related protein CD9, and MMP9 in osteoclasts derived from RAW264.7. Our findings support a new mechanism of DOT1L-mediated H3K79me2 epigenetic regulation of osteoclast differentiation, implicating DOT1L as a new therapeutic target for osteoclast dysregulation-induced disease.

INSTRUMENT(S): Orbitrap Fusion

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Cell Culture, Macrophage

DISEASE(S): Osteoporosis

SUBMITTER: Wei Ge  

LAB HEAD: wei.ge

PROVIDER: PXD006448 | Pride | 2018-01-24

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
MS160744-A1.msf Msf
MS160744-A10.raw Raw
MS160744-A11.raw Raw
MS160744-A12.raw Raw
MS160744-A13.raw Raw
Items per page:
1 - 5 of 42
altmetric image

Publications

The histone methyltransferase DOT1L inhibits osteoclastogenesis and protects against osteoporosis.

Gao Yanpan Y   Ge Wei W  

Cell death & disease 20180118 2


Osteoclasts are absorptive cells that play a critical role in homeostatic bone remodeling and pathological bone resorption. Emerging evidence suggests an important role of epigenetic regulation in osteoclastogenesis. In this study, we investigated the role of DOT1L, which regulates gene expression epigenetically by histone H3K79 methylation (H3K79me), during osteoclast formation. Using RANKL-induced RAW264.7 macrophage cells as an osteoclast differentiation model, we found that DOT1L and H3K79me  ...[more]

Similar Datasets

2024-07-21 | GSE234221 | GEO
2021-06-07 | PXD023578 | Pride
2010-08-24 | E-GEOD-21639 | biostudies-arrayexpress
2011-04-29 | E-GEOD-28937 | biostudies-arrayexpress
2010-03-22 | E-GEOD-20850 | biostudies-arrayexpress
2021-06-05 | GSE164826 | GEO
2022-09-15 | GSE202932 | GEO
2022-05-17 | GSE193800 | GEO
2010-08-24 | GSE21639 | GEO
2024-05-01 | GSE231933 | GEO